Urinary free cortisone and the assessment of 11β-hydroxysteroid dehydrogenase activity in man

Clinical Endocrinology

Volumn 45, Issue 5, 1996, Pages 605-611

  Palermo, Mario ^a   Shackleton, Cedric H L ^a   Manterof, Franco ^b   Stewart, Paul M ^c  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTISONE; HYDROCORTISONE; MINERALOCORTICOID; TETRAHYDROCORTISOL;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; FEMALE; GLYCYRRHIZA; HUMAN; HYPOPITUITARISM; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STEROID METABOLISM;

EID: 0029847585     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.00853.x     Document Type: Article

References (35)

1. Albiston, A.L., Obeyesekere, V.R., Smith, R.E. & Krozowski, Z.S. (1994) Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Molecular and Cellular Endocrinology, 105, R11-R17.
2. Arriza, J.L., Weinberger, C., Cerelli, G., et al. (1987) Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science, 237, 268-275.
3. Brown, R.W., Chapman, K.E., Edwards, C.R.W. & Seckl, J.R. (1993) Human placental 11β-hydroxysteroid dehydrogenase: Evidence for and partial purification of a distinct NAD-dependent isoform. Endocrinology, 132, 2614-2621.
4. Dunne, F.P., Elliot, P., Gammage, M.D., Stallard, T., Ryan, T., Sheppard, M.C. & Stewart, P.M. (1995) Cardiovascular function and hydrocortisone replacement regimes in patients with hypopituitarism. Clinical Endocrinology, 43, 623-629.
5. Edwards, C.R.W., Stewart, P.M., Burt, D., Brett, L., McIntyre, M., Sutano, W.S., de Kloet, E.R. & Monder, C. (1988) Localisation of 11β-hydroxysteroid dehydrogenase tissue specific protector of the mineralocorticoid receptor. Lancet, ii, 836-841.
6. Funder, J.W., Pearce, P.T., Smith, R. & Smith. A.I. (1988) Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science, 242, 583-585.
7. Hellman, L., Nakada, F., Zumoff, B., Fukushima, D., Bradlow, H.L. & Gallagher, T.F. (1971) Renal capture and oxidation of cortisol in man. Journal of Clinical Endocrinology, 33, 52-62.
8. MacKenzie, M.A., Hoefnagels, W.H.L., Jansen, R.W.M.M., Bernard, T.J. & Kloppenborg, P.W.C. (1990) The influence of glycyrrhetinic acid on plasma cortisol and cortisone in healthy young volunteers. Journal of Clinical Endocrinology and Metabolism, 70, 1637-1643.
9. Mantero, F., Tedde, R., Opocher, G., Fulgheri, P.D., Arnaldi, G. & Ulick, S. (1994) Apparent mineralocorticoid excess type II. Steroids, 59, 80-83.
10. Milford, D.V., Shackleton, C.H.L. & Stewart, P.M. (1995) Mineralocorticoid hypertension and congenital deficiency of 11β-hydroxysteroid dehydrogenase in a family with the syndrome of 'apparent' mineralocorticoid excess. Clinical Endocrinology, 43, 242-246.
11. Monder, C., Stewart, P.M., Lakshmi, V., Valentino, R., Burt, D. & Edwards, C.R.W. (1989) Liquorice inhibits corticosteroid 11β-dehydrogenase of rat kidney and liver: in vivo and in vitro studies. Endocrinology, 125, 1046-1053.
12. Moore, C.C.D., Mellon, S.H., Murai, J., Siiteri, P.K. & Miller, W.L. (1993) Structure and function of the hepatic form of 11β-hydroxysteroid dehydrogenase in the squirrel monkey, an animal model of glucocorticoid resistance. Endocrinology, 133, 368-375.
13. Mune, T., Rogerson, F.M., Nikkila, H., Agarwal, A.K. & White, P.C. (1995) Human hypertension caused by mutations in the kidney isozymc of 11β-hydroxysteroid dehydrogenase. Nature Genetics, 10, 394-399.
14. Oelkers, W., Buchen, S., Diederich, S., Krain, J., Muhme, S. & Schoneshofer, M. (1994) Impaired renal 11β-oxidation of 9α-fluorocortisol: an explanation for its mineralocorticoid potency. Journal of Clinical Endocrinology and Metabolism, 78, 928-932.
15. Rodin, A., Thakkar, H., Taylor, N. & Clayton, R.N. (1994) Hyperandrogenism in polycystic ovary syndrome: evidence of dysregulation of 11β-hydroxysteroid dehydrogenase. New England Journal of Medicine, 330, 460-465.
16. Shackleton, C.H.L. (1993) Mass spectrometry in the diagnosis of steroid-related disorders and hypertension research. Journal of Steroid Biochemistry and Molecular Biology, 45, 127-140.
17. Shackleton, C.H.L. & Stewart, P.M. (1990) The hypertension of apparent mineralocorticoid excess (AME) syndrome. In: Biglieri EG, Melby JC (eds). Endocrine Hypertension, pp155-173. New York, Raven Press.
18. Soro, A., Ingram, M.C., Tonolo. G., Glorioso, N. & Fraser, R. (1995) Evidence of reduced 11β-hydroxysteroid dehydrogenase and 5β-reductase activity in patients with untreated essential hypertension. Hypertension, 25, 67-72.
19. Stewart, P.M., Wallace, A.M., Valentine, R., Burt, D., Shackleton, C.H.L. & Edwards, C.R.W. (1987) Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase comes of age. Lancet, ii, 821-824.
20. Stewart, P.M., Corrie, J.E.T., Shackleton, C.H.L. & Edwards, C.R.W. (1988) The syndrome of apparent mineralocorticoid excess: a defect in the cortisol - cortisone shuttle. Journal of Clinical Investigation, 82, 340-349.
21. Stewart, P.M., Krozowski, Z.S., Gupta, A., Milford, D.V., Howie, A.J., Sheppard, M.C. & Whorwood, C.B. (1996) Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11β-hydroxysteroid dehydrogenase type 2 gene. Lancet, 347, 88-91.
22. Stewart, P.M., Murry, B.A. & Mason, J.I. (1994) Human kidney 11β-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type 1 isoform. Journal of Clinical Endocrinology and Metabolism, 79, 480-484.
23. Stewart, P.M., Walker, B.R., Holder, G., O'Halloran, D. & Shackleton, C.H.L. (1995) 11β-hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic ACTH syndrome. Journal of Clinical Endocrinology and Metabolism. 80, 3617-3620.
24. Tannin, G.M., Agarwal, A.K., Monder, C., New. M.I. & White, P.C. (1991) The human gene for 11β-hydroxysteroid dehydrogenase. Journal of Biological Chemistry. 266, 16653-16658.
25. Ulick, S., Tedde, R. & Mantero, F. (1990) Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess. Journal of Clinical Endocrinology and Metabolism. 70, 200-206.
26. Ulick, S., Tedde, R. & Wang, J.Z. (1992a) Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess. Journal of Clinical Endocrinology and Metabolism, 74, 593-599.
27. Ulick, S., Wang, J.Z., Blumenfeld, J.D. & Pickering, T.G. (1992b) Cortisol inactivation overload: a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome. Journal of Clinical Endocrinology and Metabolism, 74, 963-967.
28. Walker, B.R., Campbell, J.C., Fraser, R., Stewart, P.M. & Edwards, C.R.W. (1992) Mineralocorticoid excess and inhibition of 11β-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clinical Endocrinology. 37, 483-492.
29. Walker, B.R., Stewart, P.M., Shackleton, C.H.L., Padfield, P.L. & Edwards, C.R.W. (1993) Deficient inactivation of cortisol by 11β-hydroxysteroid dehydrogenase in essential hypertension. Clinical Endocrinology, 39, 221-227.
30. Weaver, J.U., Thaventhiran, L., Noonan, K., Burrin, J.M., Taylor, N.F., Norman, M.R. & Monson, J.P. (1994) The effect of growth hormone replacement therapy on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults. Clinical Endocrinology, 41, 639-648.
31. Whitworth, J.A., Stewart, P.M., Burt, D., Atherden, S.M. & Edwards, C.R.W. (1989) The kidney is the major site of cortisone production in man. Clinical Endocrinology, 31, 355-361.
32. Whorwood, C.B., Sheppard, M.C. & Stewart, P.M. (1993) Licorice inhibits 11β-hydroxysteroid dehydrogenase gene expression and potentiates glucocorticoid hormone action. Endocrinology, 132, 2287-2292.
33. Whorwood, C.B., Mason, J.I., Ricketts, M.L., Howie, A.J. & Stewart, P.M. (1995) Detection of human 11β-hydroxysteroid dehydrogenase isoforms using RT-PCR and localization of the type 2 isoform to renal collecting ducts. Molecular and Cellular Endocrinology, 110, R7-R12.
34. Wilson, R.C., Krozowski, Z.S., Li, K., et al. (1995) A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. Journal of Clinical Endocrinology and Metabolism, 80, 2263-2266.
35. Zumoff, B., Bradlow, H.L., Levin, J. & Fukushima, D.K. (1983) Influence of thyroid function on the in vivo cortisol-cortisone equilibrium in man. Journal of Steroid Biochemistry, 18, 437-440.